Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Published ...

Merck KGaA is nearing a deal to acquire SpringWorks Therapeutics Inc., people familiar with the matter said. An announcement may come as soon as Monday, the people said, asking not to be ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on SMMT: Disclaimer & Disclosure Report an Issue Summit Therapeutics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

CAMBRIDGE, Mass., April 25, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it ...

Get his next trade alert for free, right here. Summit Therapeutics Inc SMMT stock is trading lower on Friday. On Thursday, Summit Therapeutics’ partner Akeso Inc. received the U.S. Food and Drug ...

As we move forward in 2025, I want to express my sincere gratitude for your continued support and confidence in NeuroSense Therapeutics and provide a brief update and overview on each of these key ...

Mosaic Therapeutics, Ltd ('Mosaic') a targeted oncology therapeutics company dedicated to resolving cancer's complexity with new combination therapies for patients, today announces the in ...

April 25, 2025, Seattle, WA - NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its Founder and CMO, Jeff M. Sands, M.D., is the recipient of the ...

Poster presentation on Monday, June 2, 2025 from 1:30 - 4:30 PM CDT at the ASCO Annual Meeting MIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea” or the ...

The Motley Fool has positions in and recommends Summit Therapeutics. The Motley Fool recommends BioNTech Se. The Motley Fool has a disclosure policy. 2 Stocks That Have More Than Doubled in the ...

Ring Therapeutics, Sana Biotechnology, Senda Biosciences, Sigilon Therapeutics, Syros Pharma, Tessera, Valo, and Vesalius. Paul Biondi, president of Flagship's Pioneering Medicines unit ...

"We are excited to have such a substantial presence at both the Eyecelerator and ARVO annual meetings and look forward to sharing more about the positive therapeutic benefits seen in RP patients ...